California stem cell agency faces cash freeze Stem cell agency signs deal with U.K. State’s budget crisis could strain stem cell research efforts The University of California Davis has been awarded $7 million from the state stem cell agency to …
First, the stem cell policy. Researchers will still be unable to use federal money to derive new human embryonic stem cells, as a Congressional ban called the Dickey-Wicker Amendment prohibits that. Still, federal money will eventually flow to those …
Until now, it has been extremely difficult to control stem cells in such a way that they grow into new blood vessels outside the body, or — when injected into an organ — lead to the creation of new small blood vessels and tissue repair. New research has resulted in a method whereby the cells can be instructed. This is a great advance towards curing numerous life-threatening diseases.
Researchers have discovered an added layer of complexity in the network that determines human embryonic stem cell fate. A report publishing online April 30th in the journal Cell, a Cell Press publication, shows that a microRNA known as miR-145 lowers …
I can’t remember an issue in which there was so much intellectual dishonesty or malpractice in media reporting than the embryonic stem cell/cloning debates–and that’s saying a lot! For example, when the Stowers Crowd began using the junk biological …
destinyland writes “In China’s Guangdong Province there’s been ‘almost miraculous’ progress in actually using stem cells to treat diseases such as brain injury, cerebral palsy, ataxia and other optic nerve damage, lower limb ischemia, autism, spinal muscular atrophy, and multiple sclerosis. One Chinese biotech company, Beike, is now building a 21,500 square foot stem cell storage facility and …
In a study featured on the cover of the May issue of The FASEB Journal, researchers describe how they are able to reprogram human adult skin cells into other cell types in order to decipher the elusive mechanisms underlying reprogramming. To demonstrate their point, they transformed human skin cells into mouse muscle cells and vice versa. This research shows that by understanding the regulation of cell specialization it may be possible to convert one cell type into another, eventually bypassing stem cells.
ReNeuron, a leading UK-based stem cell company, today announced the publication of a paper in the journal Biotechnology Letters demonstrating successful automation of the manufacturing of its ReN001 neural stem cell line for stroke in TAP’s CompacT …
“Regenerative Medicine – New Frontiers in Cellular and Stem Cell Therapies and Tissue Engineering”